| Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London P Telfer, P Coen, S Chakravorty, O Wilkey, J Evans, H Newell, B Smalling, ... haematologica 92 (7), 905-912, 2007 | 369 | 2007 |
| Sickle cell disease: a neglected chronic disease of increasing global health importance S Chakravorty, TN Williams Archives of disease in childhood 100 (1), 48-53, 2015 | 301 | 2015 |
| How I manage neonatal thrombocytopenia S Chakravorty, I Roberts British journal of haematology 156 (2), 155-162, 2012 | 135 | 2012 |
| Neonatal thrombocytopenia S Chakravorty, N Murray, I Roberts Early human development 81 (1), 35-41, 2005 | 102 | 2005 |
| The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2 B Jessen, SFN Bode, S Ammann, S Chakravorty, G Davies, J Diestelhorst, ... Blood, The Journal of the American Society of Hematology 121 (15), 2943-2951, 2013 | 85 | 2013 |
| White matter integrity and processing speed in sickle cell anemia H Stotesbury, FJ Kirkham, M Kölbel, P Balfour, JD Clayden, S Sahota, ... Neurology 90 (23), e2042-e2050, 2018 | 78 | 2018 |
| Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID‐19 pandemic NBA Roy, P Telfer, P Eleftheriou, J de la Fuente, E Drasar, F Shah, ... British journal of haematology 189 (4), 635-639, 2020 | 59 | 2020 |
| Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients P Telfer, J De la Fuente, M Sohal, R Brown, P Eleftheriou, N Roy, FB Piel, ... Haematologica 105 (11), 2651, 2020 | 46 | 2020 |
| Associations between environmental factors and hospital admissions for sickle cell disease FB Piel, S Tewari, V Brousse, A Analitis, A Font, S Menzel, S Chakravorty, ... Haematologica 102 (4), 666, 2017 | 44 | 2017 |
| COVID-19 in patients with sickle cell disease–a case series from a UK tertiary hospital S Chakravorty, G Padmore-Payne, F Ike, V Tshibangu, C Graham, D Rees, ... Haematologica 105 (11), 2691, 2020 | 40 | 2020 |
| Disruption of AP3B1by a chromosome 5 inversion: a new disease mechanism in Hermansky-Pudlak syndrome type 2 ML Jones, SL Murden, C Brooks, V Maloney, RA Manning, KC Gilmour, ... BMC medical genetics 14, 1-6, 2013 | 40 | 2013 |
| Hermansky–Pudlak syndrome WDJ Rojas, LR Young Seminars in Respiratory and Critical Care Medicine 41 (02), 238-246, 2020 | 34 | 2020 |
| Not being heard: barriers to high quality unplanned hospital care during young people’s transition to adult services–evidence from ‘this sickle cell life’research A Renedo, S Miles, S Chakravorty, A Leigh, P Telfer, JO Warner, ... BMC health services research 19, 1-11, 2019 | 34 | 2019 |
| Patient-reported experience measure in sickle cell disease S Chakravorty, A Tallett, C Witwicki, H Hay, C Mkandawire, A Ogundipe, ... Archives of Disease in Childhood 103 (12), 1104-1109, 2018 | 28 | 2018 |
| Antenatal screening for haemoglobinopathies: current status, barriers and ethics S Chakravorty, MC Dick British journal of haematology 187 (4), 431-440, 2019 | 27 | 2019 |
| Instrumental, terrestrial and marine records of the climate of South Asia during the Holocene: Present status, unresolved problems and societal aspects AK Singhvi, K Rupakumar, M Thamban, AK Gupta, VS Kale, RR Yadav, ... Global environmental changes in South Asia: A regional perspective, 54-124, 2010 | 27 | 2010 |
| A gain of function variant in PIEZO1 (E756del) and sickle cell disease H Rooks, J Brewin, K Gardner, S Chakravorty, S Menzel, A Hannemann, ... Haematologica 104 (3), e91, 2019 | 25 | 2019 |
| Impairment of neutrophil oxidative burst in children with sickle cell disease is associated with heme oxygenase-1 C Evans, K Orf, E Horvath, M Levin, J De La Fuente, S Chakravorty, ... Haematologica 100 (12), 1508, 2015 | 25 | 2015 |
| Clinical management of sickle cell liver disease in children and young adults E Kyrana, D Rees, F Lacaille, E Fitzpatrick, M Davenport, N Heaton, ... Archives of disease in childhood 106 (4), 315-320, 2021 | 24 | 2021 |
| Overnight auto-adjusting continuous airway pressure+ standard care compared with standard care alone in the prevention of morbidity in sickle cell disease phase II (POMS2b … J Howard, AE Slee, S Skene, B Inusa, J Kawadler, M Downes, J Gavlak, ... Trials 19, 1-10, 2018 | 20 | 2018 |
